FMS Fresenius Medical Care
- 20.890
- +0.210+1.02%
Fresenius Medical Care News
Fresenius Medical Care's (ETR:FME) Upcoming Dividend Will Be Larger Than Last Year's
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q1 2024 Earnings Call Transcript
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading
European equities traded in the US as American depositary receipts were trending modestly higher late Wednesday morning, rising 0.34% to 1,399.71 on the S&P Europe Select ADR Index. From continental E
Fresenius's Exit of Vamed Business Is a Positive -- Market Talk
0944 GMT - Fresenius's initiation to exit its Vamed business, seen as a drag on profitability, should be welcomed by investors, Berenberg analysts say in a note. The analysts estimate that the divestm
Analysts' Top Healthcare Picks: Fresenius Medical Care AG & Co. KGaA (GB:0H9X), Omega Therapeutics (OMGA)
Correction to Fresenius Medical Care Article on Tuesday
Fresenius Medical Care reported results for the first quarter. "Fresenius Medical Care Shares Drop on Profit Fall," at 0855 GMT on Tuesday, misstated the company name in the third paragraph.
Fresenius Shares Rise After Guidance Lift, Vamed Exit
By Helena Smolak Fresenius shares rose after the company lifted its full-year guidance on rising first-quarter net profit that beat expectations and said it started the exit from its investment compa
Fresenius Medical Care First Quarter 2024 Earnings: EPS Beats Expectations
Research Alert: CFRA Keeps Sell Opinion On Adss Of Fresenius Medical Care
CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows: We keep our target price of $17, implyin
Earnings Call Summary | Fresenius Medical Care(FMS.US) Q1 2024 Earnings Conference
The following is a summary of the Fresenius Medical Care AG (FMS) Q1 2024 Earnings Call Transcript:Financial Performance:Fresenius reported a Q1 revenue growth of 4%, driven by contributions from both
Sector Update: Health Care
Health care stocks rose late Tuesday afternoon with the NYSE Health Care Index adding 0.9% and the Health Care Select Sector SPDR Fund (XLV) up 0.8%. The iShares Biotechnology ETF (IBB) rose 0.3%. In
Fresenius Medical Care Shares Decline Following Q1 Results
Fresenius Medical Care (FMS) shares were down more than 6% in recent Tuesday trading after the company reported its Q1 earnings. The company reported Q1 earnings of 0.24 euro ($0.26) per share, down f
Fresenius Down 6% Despite Bottom Line Beat
Fresenius Medical Care Reports Q1 Results, Confirms Outlook
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday
Bank stocks helped European equities traded in the US as American depositary receipts higher late Tuesday morning, rising 0.77% to 1,396.19 on the S&P Europe Select ADR Index. From continental Europe,
Fresenius Medical Care 1Q Rev EUR4.72B >FMS
Fresenius Medical Care 1Q Rev EUR4.72B >FMS
Press Release: Fresenius Medical Care Starts the Year With Strong Earnings Growth
Fresenius Medical Care starts the year with strong earnings growth PR Newswire BAD HOMBURG, Germany, May 7, 2024 -- Solid revenue1 growth of 4% driven by both segments Care Delivery and Ca
6-K: Report of foreign private issuer (related to financial reporting)
AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
U.S. stock futures were mostly higher this morning, with the Dow futures gaining around 80 points on Tuesday.
Changes in US stocks | Fresenius Healthcare fell nearly 8% in the premarket, net revenue fell in the first quarter
Glonghui May 7 | Fresenius Healthcare (FMS.US) fell 7.89% to $19.73 before the market. The company's net shareholders' revenue for the first quarter fell 18% to €71 million; basic earnings per share fell 18% to €0.24. The company confirmed its outlook for the 2024 fiscal year and expects revenue to grow at a low to medium rate in single digits.
Analysis
Price Target
No Data
